Skip to main content
Top
Published in: Virology Journal 1/2011

Open Access 01-12-2011 | Research

Evolutionary variation of papillomavirus E2 protein and E2 binding sites

Authors: Adam Rogers, Mackenzie Waltke, Peter C Angeletti

Published in: Virology Journal | Issue 1/2011

Login to get access

Abstract

Background

In an effort to identify the evolutionary changes relevant to E2 function, within and between papillomavirus genera, we evaluated the E2 binding sites (E2BS)s inside the long-control-region (LCR), and throughout the genomes. We identified E2BSs in the six largest genera of papillomaviruses: Alpha, Beta, Gamma, Delta, Lambda, and Xi-papillomaviruses (128 genomes), by comparing the sequences with a model consensus we created from known functional E2BSs (HPV16, HPV18, BPV1). We analyzed the sequence conservation and nucleotide content of the 4-nucleotide spacer within E2BSs. We determined that there is a statistically significant difference in GC content of the four-nucleotide E2BS spacer, between Alpha and Delta-papillomaviruses, as compared to each of the other groups. Additionally, we performed multiple alignments of E2 protein sequences using members of each genus in order to identify evolutionary changes within the E2 protein.

Results

When a phylogenetic tree was generated from E2 amino acid sequences, it was discovered that the alpha-papillomavirus genera segregates into two distinct subgroups (α1 and α2). When these subgroups were individually analyzed, it was determined that the subgroup α1 consensus E2BS favored a spacer of AAAA, whereas subgroup α2 favored the opposite orientation of the same spacer; TTTT. This observation suggests that these conserved inverted linkers could have functional importance.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference Day PM, Lowy DR, Schiller JT: Papillomaviruses infect cells via a clathrin-dependent pathway. Virology 2003, 307: 1-11. 10.1016/S0042-6822(02)00143-5CrossRefPubMed Day PM, Lowy DR, Schiller JT: Papillomaviruses infect cells via a clathrin-dependent pathway. Virology 2003, 307: 1-11. 10.1016/S0042-6822(02)00143-5CrossRefPubMed
3.
go back to reference Bosch FX, Sanjose S, Castellsague X, Moreno V, Munoz N: Papillomavirus Research: From Natural History to Vaccines and Beyond. Edited by: Saveria Campo M. Wymondham: Caisreir Academic Press; 2006:19-40. Bosch FX, Sanjose S, Castellsague X, Moreno V, Munoz N: Papillomavirus Research: From Natural History to Vaccines and Beyond. Edited by: Saveria Campo M. Wymondham: Caisreir Academic Press; 2006:19-40.
4.
go back to reference Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S: Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003, 88: 63-73. 10.1038/sj.bjc.6600688PubMedCentralCrossRefPubMed Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S: Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003, 88: 63-73. 10.1038/sj.bjc.6600688PubMedCentralCrossRefPubMed
5.
go back to reference Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ: Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003, 348: 518-527. 10.1056/NEJMoa021641CrossRefPubMed Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ: Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003, 348: 518-527. 10.1056/NEJMoa021641CrossRefPubMed
6.
go back to reference D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, Westra WH, Gillison ML: Case-Control Study of Human Papillomavirus and Oropharyngeal Cancer. N Engl J Med 2007, 356: 1944-1956. 10.1056/NEJMoa065497CrossRefPubMed D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, Westra WH, Gillison ML: Case-Control Study of Human Papillomavirus and Oropharyngeal Cancer. N Engl J Med 2007, 356: 1944-1956. 10.1056/NEJMoa065497CrossRefPubMed
7.
go back to reference de Villiers E-M, Fauquet C, Broker TR, Bernard H-U, zur Hausen H: Classification of papillomaviruses. Virology 2004, 324: 17-27. 10.1016/j.virol.2004.03.033CrossRefPubMed de Villiers E-M, Fauquet C, Broker TR, Bernard H-U, zur Hausen H: Classification of papillomaviruses. Virology 2004, 324: 17-27. 10.1016/j.virol.2004.03.033CrossRefPubMed
8.
go back to reference Hegde RS: The papillomavirus E2 proteins: structure, function, and biology. Annu Rev Biophys Biomol Struct 2002, 31: 343-360. 10.1146/annurev.biophys.31.100901.142129CrossRefPubMed Hegde RS: The papillomavirus E2 proteins: structure, function, and biology. Annu Rev Biophys Biomol Struct 2002, 31: 343-360. 10.1146/annurev.biophys.31.100901.142129CrossRefPubMed
9.
go back to reference de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H: Classification of papillomaviruses. Virology 2004, 324: 17-27. 10.1016/j.virol.2004.03.033CrossRefPubMed de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H: Classification of papillomaviruses. Virology 2004, 324: 17-27. 10.1016/j.virol.2004.03.033CrossRefPubMed
10.
go back to reference Wentzensen N, Vinokurova S, von Knebel Doeberitz M: Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract. Cancer Res 2004, 64: 3878-3884. 10.1158/0008-5472.CAN-04-0009CrossRefPubMed Wentzensen N, Vinokurova S, von Knebel Doeberitz M: Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract. Cancer Res 2004, 64: 3878-3884. 10.1158/0008-5472.CAN-04-0009CrossRefPubMed
11.
go back to reference McBride AA, Romanczuk H, Howley PM: The papillomavirus E2 regulatory proteins. J Biol Chem 1991, 266: 18411-18414.PubMed McBride AA, Romanczuk H, Howley PM: The papillomavirus E2 regulatory proteins. J Biol Chem 1991, 266: 18411-18414.PubMed
12.
go back to reference Sakai H, Yasugi T, Benson JD, Dowhanick JJ, Howley PM: Targeted mutagenesis of the human papillomavirus type 16 E2 transactivation domain reveals separable transcriptional activation and DNA replication functions. J Virol 1996, 70: 1602-1611.PubMedCentralPubMed Sakai H, Yasugi T, Benson JD, Dowhanick JJ, Howley PM: Targeted mutagenesis of the human papillomavirus type 16 E2 transactivation domain reveals separable transcriptional activation and DNA replication functions. J Virol 1996, 70: 1602-1611.PubMedCentralPubMed
13.
go back to reference Antson AA, Burns JE, Moroz OV, Scott DJ, Sanders CM, Bronstein IB, Dodson GG, Wilson KS, Maitland NJ: Structure of the intact transactivation domain of the human papillomavirus E2 protein. Nature 2000, 403: 805-809. 10.1038/35001638CrossRefPubMed Antson AA, Burns JE, Moroz OV, Scott DJ, Sanders CM, Bronstein IB, Dodson GG, Wilson KS, Maitland NJ: Structure of the intact transactivation domain of the human papillomavirus E2 protein. Nature 2000, 403: 805-809. 10.1038/35001638CrossRefPubMed
14.
go back to reference Thain A, Jenkins O, Clarke A, Gaston K: CpG methylation directly inhibits binding of the human papillomavirus type 16 E2 protein to specific DNA sequences. J Virol 1996, 70: 7233-7235.PubMedCentralPubMed Thain A, Jenkins O, Clarke A, Gaston K: CpG methylation directly inhibits binding of the human papillomavirus type 16 E2 protein to specific DNA sequences. J Virol 1996, 70: 7233-7235.PubMedCentralPubMed
15.
go back to reference Ferriero DU, Delarole M, Nadra AD, De Prat Gay G: Free Energy Contributions to Direct Readout of a DNA Sequence. J Biol Chem 2005, 32480-32484. Ferriero DU, Delarole M, Nadra AD, De Prat Gay G: Free Energy Contributions to Direct Readout of a DNA Sequence. J Biol Chem 2005, 32480-32484.
16.
go back to reference Blakaj DM, Kattamuri C, Khrapunov S, Hegde RS, Brenowitz M: Indirect Readout of DNA Sequence by Papillomavirus E2 Proteins Depends Upon Net Cation Uptake. J Mol Biol 2006, 358: 224-240. 10.1016/j.jmb.2006.01.093CrossRefPubMed Blakaj DM, Kattamuri C, Khrapunov S, Hegde RS, Brenowitz M: Indirect Readout of DNA Sequence by Papillomavirus E2 Proteins Depends Upon Net Cation Uptake. J Mol Biol 2006, 358: 224-240. 10.1016/j.jmb.2006.01.093CrossRefPubMed
17.
go back to reference Dell G, Wilkinson KW, Tranter R, Parish J, Leo Brady R, Gaston K: Comparison of the Structure and DNA-binding Properties of the E2 Proteins from an Oncogenic and a Non-oncogenic Human Papillomavirus. J Mol Biol 2003, 334: 979-991. 10.1016/j.jmb.2003.10.009CrossRefPubMed Dell G, Wilkinson KW, Tranter R, Parish J, Leo Brady R, Gaston K: Comparison of the Structure and DNA-binding Properties of the E2 Proteins from an Oncogenic and a Non-oncogenic Human Papillomavirus. J Mol Biol 2003, 334: 979-991. 10.1016/j.jmb.2003.10.009CrossRefPubMed
18.
go back to reference Hines CS, Meghoo C, Shetty S, Biburger M, Brenowitz M, Hegde RS: DNA structure and flexibility in the sequence-specific binding of papillomavirus E2 proteins. J Mol Biol 1998, 276: 809-818. 10.1006/jmbi.1997.1578CrossRefPubMed Hines CS, Meghoo C, Shetty S, Biburger M, Brenowitz M, Hegde RS: DNA structure and flexibility in the sequence-specific binding of papillomavirus E2 proteins. J Mol Biol 1998, 276: 809-818. 10.1006/jmbi.1997.1578CrossRefPubMed
19.
go back to reference Li R, Knight J, Bream G, Stenlund A, Botchan M: Specific recognition nucleotides and their DNA context determine the affinity of E2 protein for 17 binding sites in the BPV-1 genome. Genes & Development 1989, 510-526. Li R, Knight J, Bream G, Stenlund A, Botchan M: Specific recognition nucleotides and their DNA context determine the affinity of E2 protein for 17 binding sites in the BPV-1 genome. Genes & Development 1989, 510-526.
20.
go back to reference Sanchez IE, Dellarole M, Gaston K, de Prat Gay G: Comprehensive comparison of the interaction of the E2 master regulator with its cognate target DNA sites in 73 human papillomavirus types by sequence statistics. Nucl Acids Res 2008, 36: 756-769.PubMedCentralCrossRefPubMed Sanchez IE, Dellarole M, Gaston K, de Prat Gay G: Comprehensive comparison of the interaction of the E2 master regulator with its cognate target DNA sites in 73 human papillomavirus types by sequence statistics. Nucl Acids Res 2008, 36: 756-769.PubMedCentralCrossRefPubMed
21.
go back to reference Yongli Zhang, Zhiqun Xi, Rashmi S Hegde, Zippora Shakked, Crothers aDM: Predicting indirect readout effects in protein-DNA interactions. PNAS 2004, 101: 8337-8341. 10.1073/pnas.0402319101CrossRef Yongli Zhang, Zhiqun Xi, Rashmi S Hegde, Zippora Shakked, Crothers aDM: Predicting indirect readout effects in protein-DNA interactions. PNAS 2004, 101: 8337-8341. 10.1073/pnas.0402319101CrossRef
22.
go back to reference M Remm RB, Jenkins JR: The E2 binding sites determine the efficiency of replication for the origin of human papillomavirus type 18. Nucleic Acids Res 1992, 20: 6015-6021. 10.1093/nar/20.22.6015CrossRef M Remm RB, Jenkins JR: The E2 binding sites determine the efficiency of replication for the origin of human papillomavirus type 18. Nucleic Acids Res 1992, 20: 6015-6021. 10.1093/nar/20.22.6015CrossRef
23.
go back to reference Corbach GSaS: Dose-dependent regulation of the early promoter of human papillomavirus type 18 by the viral E2 protein. J Virol 1997, 71: 50-58. Corbach GSaS: Dose-dependent regulation of the early promoter of human papillomavirus type 18 by the viral E2 protein. J Virol 1997, 71: 50-58.
24.
go back to reference Ensser A, Pfister H: Epidermodysplasia verruciformis associated human papilomaviruses present a subgenus-specific organization of the regulatory genome region. Nucl Acids Res 1990, 18: 3919-3922. 10.1093/nar/18.13.3919PubMedCentralCrossRefPubMed Ensser A, Pfister H: Epidermodysplasia verruciformis associated human papilomaviruses present a subgenus-specific organization of the regulatory genome region. Nucl Acids Res 1990, 18: 3919-3922. 10.1093/nar/18.13.3919PubMedCentralCrossRefPubMed
25.
go back to reference Piirsoo M, Ustav E, Mandel T, Stenlund A, Ustav M: Cis and trans requirements for stable episomal maintenance of the BPV-1 replicator. Embo J 1996, 15: 1-11.PubMedCentralPubMed Piirsoo M, Ustav E, Mandel T, Stenlund A, Ustav M: Cis and trans requirements for stable episomal maintenance of the BPV-1 replicator. Embo J 1996, 15: 1-11.PubMedCentralPubMed
26.
go back to reference Stubenrauch F, Lim HB, Laimins LA: Differential requirements for conserved E2 binding sites in the life cycle of oncogenic human papillomavirus type 31. J Virol 1998, 72: 1071-1077.PubMedCentralPubMed Stubenrauch F, Lim HB, Laimins LA: Differential requirements for conserved E2 binding sites in the life cycle of oncogenic human papillomavirus type 31. J Virol 1998, 72: 1071-1077.PubMedCentralPubMed
27.
go back to reference Sverdrup F, Khan SA: Two E2 binding sites alone are sufficient to function as the minimal origin of replication of human papillomavirus type 18 DNA. J Virol 1995, 69: 1319-1323.PubMedCentralPubMed Sverdrup F, Khan SA: Two E2 binding sites alone are sufficient to function as the minimal origin of replication of human papillomavirus type 18 DNA. J Virol 1995, 69: 1319-1323.PubMedCentralPubMed
28.
go back to reference Li R, Knight J, Bream G, Stenlund A, Botchan M: Specific recognition nucleotides and their DNA context determine the affinity of E2 protein for 17 binding sites in the BPV-1 genome. Genes & Development 1989, 3: 510-526. 10.1101/gad.3.4.510CrossRef Li R, Knight J, Bream G, Stenlund A, Botchan M: Specific recognition nucleotides and their DNA context determine the affinity of E2 protein for 17 binding sites in the BPV-1 genome. Genes & Development 1989, 3: 510-526. 10.1101/gad.3.4.510CrossRef
29.
go back to reference Bailey TL, Elkan C: Fitting a mixture model by expectation maximization to discover motifs in biopolymers. In Proceedings of the Second International Conference on Intelligent Systems for Molecular Biology. Menlo Park, California: AAAI Press; 1994:28-36. Bailey TL, Elkan C: Fitting a mixture model by expectation maximization to discover motifs in biopolymers. In Proceedings of the Second International Conference on Intelligent Systems for Molecular Biology. Menlo Park, California: AAAI Press; 1994:28-36.
30.
go back to reference Chapter 17, The Reference Sequence (RefSeq) Project In The NCBI handbook. Bethesda: National Library of Medicine (US), National Center for Biotechnology Information; 2002. Chapter 17, The Reference Sequence (RefSeq) Project In The NCBI handbook. Bethesda: National Library of Medicine (US), National Center for Biotechnology Information; 2002.
31.
go back to reference Olson M HL, Cantor C, Botstein D: A common language for physical mapping of the human genome. Science 1989, 245: 1434-1435. 10.1126/science.2781285CrossRefPubMed Olson M HL, Cantor C, Botstein D: A common language for physical mapping of the human genome. Science 1989, 245: 1434-1435. 10.1126/science.2781285CrossRefPubMed
32.
go back to reference Pruitt KDT, T Maglott DR: NCBI Reference Sequence (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins. Nucleic Acids Res 2007,35(Database):D61-35. 10.1093/nar/gkl842PubMedCentralCrossRefPubMed Pruitt KDT, T Maglott DR: NCBI Reference Sequence (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins. Nucleic Acids Res 2007,35(Database):D61-35. 10.1093/nar/gkl842PubMedCentralCrossRefPubMed
33.
go back to reference Bailey TL, Gribskov M: Combining evidence using p-values: application to sequence homology searches. Bioinformatics 1998, 14: 48-54. 10.1093/bioinformatics/14.1.48CrossRefPubMed Bailey TL, Gribskov M: Combining evidence using p-values: application to sequence homology searches. Bioinformatics 1998, 14: 48-54. 10.1093/bioinformatics/14.1.48CrossRefPubMed
34.
35.
go back to reference Papadopoulos JS, Agarwala R: COBALT: constraint-based alignment tool for multiple protein sequences. Bioinformatics 2007, 23: 1073-1079. 10.1093/bioinformatics/btm076CrossRefPubMed Papadopoulos JS, Agarwala R: COBALT: constraint-based alignment tool for multiple protein sequences. Bioinformatics 2007, 23: 1073-1079. 10.1093/bioinformatics/btm076CrossRefPubMed
36.
go back to reference Narechania A, Terai M, Burk RD: Overlapping reading frames in closely related human papillomaviruses result in modular rates of selection within E2. J Gen Virol 2005, 86: 1307-1313. 10.1099/vir.0.80747-0CrossRefPubMed Narechania A, Terai M, Burk RD: Overlapping reading frames in closely related human papillomaviruses result in modular rates of selection within E2. J Gen Virol 2005, 86: 1307-1313. 10.1099/vir.0.80747-0CrossRefPubMed
37.
go back to reference Strauss JK, Maher LJ: DNA bending by asymmetric phosphate neutralization. Science 1994, 266: 1829-1834. 10.1126/science.7997878CrossRefPubMed Strauss JK, Maher LJ: DNA bending by asymmetric phosphate neutralization. Science 1994, 266: 1829-1834. 10.1126/science.7997878CrossRefPubMed
38.
go back to reference Kerppola TK, Curran T: The transcription activation domains of Fos and Jun induce DNA bending through electrostatic interactions. Embo J 1997, 16: 2907-2916. 10.1093/emboj/16.10.2907PubMedCentralCrossRefPubMed Kerppola TK, Curran T: The transcription activation domains of Fos and Jun induce DNA bending through electrostatic interactions. Embo J 1997, 16: 2907-2916. 10.1093/emboj/16.10.2907PubMedCentralCrossRefPubMed
39.
go back to reference Li R, Knight J, Bream G, Stenlund A, Botchan M: Specific recognition nucleotides and their DNA context determine the affinity of E2 protein for 17 binding sites in the BPV-1 genome. Genes Dev 1989, 3: 510-526. 10.1101/gad.3.4.510CrossRefPubMed Li R, Knight J, Bream G, Stenlund A, Botchan M: Specific recognition nucleotides and their DNA context determine the affinity of E2 protein for 17 binding sites in the BPV-1 genome. Genes Dev 1989, 3: 510-526. 10.1101/gad.3.4.510CrossRefPubMed
40.
go back to reference Mistry N, Simonsson M, Evander M: Transcriptional activation of the human papillomavirus type 5 and 16 long control region in cells from cutaneous and mucosal origin. Virol J 2007, 4: 27. 10.1186/1743-422X-4-27PubMedCentralCrossRefPubMed Mistry N, Simonsson M, Evander M: Transcriptional activation of the human papillomavirus type 5 and 16 long control region in cells from cutaneous and mucosal origin. Virol J 2007, 4: 27. 10.1186/1743-422X-4-27PubMedCentralCrossRefPubMed
41.
go back to reference Sailaja G, Watts RM, Bernard HU: Many different papillomaviruses have low transcriptional activity in spite of strong epithelial specific enhancers. J Gen Virol 1999,80(Pt 7):1715-1724.CrossRefPubMed Sailaja G, Watts RM, Bernard HU: Many different papillomaviruses have low transcriptional activity in spite of strong epithelial specific enhancers. J Gen Virol 1999,80(Pt 7):1715-1724.CrossRefPubMed
42.
go back to reference McPhillips MG, Oliveira JG, Spindler JE, Mitra R, McBride AA: Brd4 Is Required for E2-Mediated Transcriptional Activation but Not Genome Partitioning of All Papillomaviruses. J Virol 2006, 80: 9530-9543. 10.1128/JVI.01105-06PubMedCentralCrossRefPubMed McPhillips MG, Oliveira JG, Spindler JE, Mitra R, McBride AA: Brd4 Is Required for E2-Mediated Transcriptional Activation but Not Genome Partitioning of All Papillomaviruses. J Virol 2006, 80: 9530-9543. 10.1128/JVI.01105-06PubMedCentralCrossRefPubMed
Metadata
Title
Evolutionary variation of papillomavirus E2 protein and E2 binding sites
Authors
Adam Rogers
Mackenzie Waltke
Peter C Angeletti
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2011
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-8-379

Other articles of this Issue 1/2011

Virology Journal 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.